20918 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Enhanced organogenesis through manipulation of LIN28/LET-7/DIS3L2
#1502Use of Hsp70 as a regulator of enzymatic activity
#1503Pharmaceutical composition and biomaterial comprising fusion peptide in which bone tissue-selective peptide bound to parathyroid hormone (PTH) or fragment thereof
#1504Use of HSP70 as a regulator of enzymatic activity
#1505Methods for reducing side effects of immunotherapy
#1506Anti-tumor properties of Dickkopf 3b
#1507Methods for the treatment of neurological disorders and diseases using FNDC5
#1508Methods and compositions for modulation of tau proteins
#1509Peptides for treatment of diabetes
#1510Antimicrobial agents and their use in therapy
#1511Selective targeting of the CD40L/Mac-1 interaction by small peptide inhibitors and its use for the treatment of inflammation and atherogenesis
#1512Compositions and methods for prevention and treatment of hearing loss
#1513Selective recovery
#1514Mutant huntingtin-mediated protein dysfunction
#1515POLYPEPTIDE-POLYMER CONJUGATES AND METHODS OF USE THEREOF
#1516Saposin-A derived peptides and uses thereof
#1517Peptides and compositions for treatment of joint damage
#1518Gene therapy for tuberous sclerosis
#1519DPEP-1 binding compositions and methods of use
#1520Method for blocking stress-induced tumor progression
#1521Lipid formulations for delivery of messenger RNA
#1522Uterine cancer treatments
#1523TREATMENT OF AGE-RELATED MACULAR DEGENERATION AND OTHER EYE DISEASES WITH APOLIPOPROTEIN MIMETICS
#1524Methods of treating inflammatory disorders with multivalent Fc compounds
#1525NUCLEIC ACID ENCODING GENETICALLY ENGINEERED GROWTH FACTOR VARIANTS
#1526GILZ formulations for wound healing
#1527Neuronal survival and axonal regeneration through increasing mitochondrial motility
#1528Use of vimentin in the modulation of acute inflammation and thrombosis
#1529Compositions and methods using a polyphenol for musculoskeletal health
#1530Mast cell stabilizers for treatment of fever
#1531Mast cell stabilizers for treatment of hypercytokinemia and viral infection
#1532COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING TYPE 1 DIABETES USING A BIOLOGIC RESPONSE MODIFIER IN COMBINATION WITH ONE OR MORE ISLET OR BETA CELL REGENERATION OR REPLACEMENT THERAPIES
#1533REGENERATING FUNCTIONAL NEURONS FOR TREATMENT OF NEURAL INJURY CAUSED BY DISRUPTION OF BLOOD FLOW
#1534Method for Precise Identification, Targeting and Delivery of Directed Therapies to Domesticated Animals Using Bacteria to Bind and Destroy Cancerous Cells
#1535Treatment for periodontitis
#1536Pegylated liposomal formulations of apelin for treatment of cardiovascular-related diseases
#1537ALK7 ANTAGONISTS AND USES THEREOF
#1538Oligonucleotides for reduction of PD-L1 expression
#1539Gene therapy for retinitis pigmentosa
#1540Compositions and Methods for Antigen-Specific Tolerance
#1541Prodrug Comprising a Drug Linker Conjugate
#1542HLA-restricted VGLL1 peptides and use thereof in promoting an immune response in a subject
#1543Ice-based lipid nanoparticle formulation for delivery of mRNA
#1544COMPOSITIONS AND METHODS OF IMPROVED WOUND HEALING
#1545RECONSTITUTED HIGH DENSITY LIPOPROTEIN TREATMENT OF MYOCARDIAL INFARCTION
#1546Methods and compositions for TUSC2 immunotherapy
#1547WOUND HEALING AGENT HAVING ANTIMICROBIAL ACTIVITY AND WOUND HEALING ACCELERATING ACTIVITY
#1548SMALL MOLECULE CANCER TREATMENTS THAT CAUSE NECROSIS IN CANCER CELLS BUT DO NOT AFFECT NORMAL CELLS
#1549Nanoparticle modification of human adipose-derived mesenchymal stem cells for treating brain cancer and other neurological diseases
#1550Human APOB100 epitopes, methods and uses for modulating inflammatory responses, and treating adverse cardiovascular events, disease and atherosclerosis
#1551Immunotherapy against several tumors, such as lung cancer, including NSCLC
#1552Immunotherapy against several tumors, such as lung cancer, including NSCLC
#1553Immunotherapy against several tumors including lung cancer
#1554Immunotherapy against several tumors including lung cancer
#1555Methods and compositions for treating Huntington's disease
#1556Tumor suppressor REC8 as a biomarker for gastric cancer
#1557METHODS AND COMPOSITIONS FOR DELIVERING ACTIVE AGENTS WITH ENHANCED PHARMACOLOGICAL PROPERTIES
#1558METHOD OF TREATING NEOPLASIAS
#1559Methods and compositions comprising a nitrite-reductase promoter for treatment of medical disorders and preservation of blood products
#1560DRY POWDER FORMULATIONS FOR MESSENGER RNA
#1561Anti-TrkB agonist antibodies binding to D5 domain of TrkB and methods of promoting neuronal survival in motor neuron injury, stroke or glaucoma
#1562Structure-based peptide inhibitors that target the Tau VQIINK fibrillization segment
#1563Methods and compositions for treating neurodegenerative disorders and Alzheimer's Disease and improving normal memory
#1564CCN3 and CCN3 peptides and analogs thereof for therapeutic use
#1565Immunotherapy against several tumors, such as lung cancer, including NSCLC
#1566Methods, compounds and compositions for modulating blood brain barrier integrity and re-myelination
#1567Treatment of age-related macular degeneration
#1568STAT5a AND ITS FUNCTIONAL TUMOR SUPPRESSOR ANALOGS FOR TREATMENT OF MALIGNANCIES EXPRESSING NPM/ALK AND OTHER ONCOGENIC KINASES
#1569THERAPIES BASED ON CONTROL OF REGULATORY T CELL STABILITY AND FUNCTION VIA A NEUROPILIN-1:SEMAPHORIN AXIS
#1570Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
#1571COMPOSITIONS AND METHODS OF CONTROLLING EXPRESSION OF THERMOGENIN (UCP-1) IN SKELETAL MUSCLES
#1572Methods for preventing or treating certain disorders by inhibiting binding of IL-4 and/or IL-13 to their respective receptors
#1573THERAPEUTICALLY ACTIVE COMPLEXES
#1574METHODS FOR INHIBITING NECROSIS
#1575Knee pain evaluation and management via WOMAC and KOOS systems
#1576Topical formulations and methods
#1577Method of managing joint pain
#1578Heparin-associated polypeptides and uses thereof
#1579Therapeutic peptides
#1580REDUCTION OF LIPASE ACTIVITY IN PRODUCT FORMULATIONS
#1581Inhibitors of neuroligin 4-neurexin 1-beta protein-protein interaction for treatment of liver disorders
#1582IMMUNOTHERAPY AGAINST MELANOMA AND OTHER CANCERS
#1583METHODS AND COMPOSITIONS FOR IMMUNOMODULATION
#1584CAPCNA PEPTIDE THERAPEUTICS FOR CANCER
#1585Formulation, dosage form and method of reducing knee pain
#1586COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR AND PULMONARY DISEASES WITH APELIN
#1587COMPOSITION AND METHOD FOR THE TREATMENT OR PREVENTION OF SPINAL DISORDERS
#1588METHODS AND COMPOSITIONS FOR TREATMENT OF IONIZING RADIATION RESISTANT TUMORS
#1589Protein Hydrogels For Treatment Of Neovascular Disease
#1590Erythropoietin-derived peptides and methods of protecting cells from oxidative damage induced by reactive oxygen species
#1591Modified ligand-gated ion channels and methods of use
#1592NAF-1 derived peptides and uses thereof
#1593Therapeutic compositions
#1594METHODS AND COMPOSITIONS OF CHONDRISOMES
#1595Immunoglobulins and uses thereof
#1596Animal model of longevity and related methods for increasing longevity and inhibiting tumorigenesis
#1597Cell-permeable (ICP)-SOCS3 recombinant protein and uses thereof
#1598ANGIOGENIC CONDITIONING TO ENHANCE CARDIAC CELLULAR REPROGRAMMING OF FIBROBLASTS OF THE INFARCTED MYOCARDIUM
#1599Combination therapy for treating disorders of the ear
#1600COMPOSITIONS AND METHODS FOR LUNG REGENERATION
#1601COMPOSITIONS AND METHODS USING AN EPIGENETIC INHIBITOR
#1602Pharmaceutical composition containing sulglycotide or pharmaceutically acceptable salt thereof for preventing or treating dry eye
#1603Treatment of angiogenesis disorders
#1604Combination Immunotherapy For The Treatment of Cancer
#1605HMGB1 tyrosine mutants
#1606Fused in sarcoma (FUS) nuclear translocation inhibitors for preventing fibrosis
#1607Methods and compositions for delivering interleukin-1 receptor antagonist
#1608Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
#1609RNA for treatment or prophylaxis of a liver disease
#1610HISTATIN FOR CORNEAL WOUND HEALING AND OCULAR SURFACE DISEASE
#1611WHEY PROTEIN MICELLES TO ENHANCE MUSCLE MASS AND PERFORMANCE
#1612AAV-MEDIATED GENE THERAPY FOR NPHP5 LCA-CILIOPATHY
#1613METHODS FOR TREATING PERIPHERAL NERVE INJURY
#1614Peptides useable for treatment of disorders of the eye
#1615Nutritional composition with resistant starch useful in the treatment of neoplastic diseases
#1616Inhibiting the onset of gout
#1617Cell-permeable (ICP)-SOCS3 recombinant protein and uses thereof
#1618Modification and compositions of human secretoglobin proteins
#1619Intrathecal delivery of recombinant adeno-associated virus 9
#1620Reversing deficient hedgehog signaling restores deficient skeletal regeneration
#1621Use of peptides that block metadherin-SND1 interaction as treatment for cancer
#1622Methods of treating Kawasaki Disease
#1623METHODS FOR THE PREVENTION OR TREATMENT OF VESSEL OCCLUSION INJURY
#1624HYALURONIC ACID-BINDING SYNTHETIC PEPTIDOGLYCANS, PREPARATION, AND METHODS OF USE
#1625Modified therapeutic agents and compositions thereof
#1626Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
#1627Materials and methods useful for treating glioblastoma
#1628METHODS FOR TREATING ISCHEMIC INJURY
#1629Pharmaceutical composition for preventing or treating metabolic diseases, comprising bacteroides acidifaciens as active ingredient
#1630Implantable solid dosage form
#1631Treatment for Dupuytren's disease
#1632Immunotherapy against melanoma and other cancers
#1633Immunotherapy against melanoma and other cancers
#1634Immunotherapy against several tumors, such as lung cancer, including NSCLC
#1635MINIMALLY-INVASIVE, HIGH RESOLUTION NEUROMODULATION OF DEEP BRAIN AND CORTICAL STRUCTURES USING CIRCUIT-SPECIFIC PROMOTERS AND FOCUSED ULTRASOUND ARRAY
#1636UNIVERSAL PLATFORM FOR TARGETING THERAPIES TO TREAT NEUROLOGICAL DISEASES
#1637Methods and compositions for modulating myofibroblast activities
#1638Immunotherapy against several tumors including gastrointestinal and gastric cancer
#1639Peptide directed protein knockdown
#1640Polymer hydrogels for in vivo applications and methods for using and preparing same
#1641TREATMENT OF HORMONAL DISORDERS OF GROWTH
#1642Composition in powder form comprising iron-milk protein complexes and probiotic bacteria
#1643Method for suppressing obesity or development of obesity
#1644Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (PD-1) pathway
#1645Fusion protein Slit2D2(C386S)-HSA and use thereof in treatment of fibrotic diseases
#1646Peptides useable for treating cancer
#1647TARGETED DRUG DELIVERY AND THERAPEUTIC METHODS USING APO-E MODIFIED LIPID NANOPARTICLES
#1648Methods for treatment of and prophylaxis against inflammatory disorders
#1649Arginine and its use as a T cell modulator
#1650Fibronectin based scaffold domain proteins that bind to myostatin
#1651Methods for treating bone loss using sclerostin peptides
#1652Composition for controlled release of therapeutic agents
#1653Inhibitors of valosin-containing protein and methods of use
#1654Methods and compositions for in vivo induction of pancreatic beta cell formation
#1655Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
#1656ACTIVATION OF THE ENDOGENOUS ILEAL BRAKE HORMONE PATHWAY FOR ORGAN REGENERATION AND RELATED COMPOSITIONS, METHODS OF TREATMENT, DIAGNOSTICS, AND REGULATORY SYSTEMS
#1657Lipoprotein complexes and manufacturing and uses thereof
#1658CONTROLLED-RELEASE APOPTOSIS MODULATING COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS
#1659Trefoil family factor proteins and uses thereof
#1660Method of reducing the likelihood of skin cancer in an individual human being
#1661Methods for treatment of cancer by targeting SIRT5
#1662Compounds and Methods to Measure Metabolic Function and Restore Normal Metabolic Function
#1663Methods of treating a disorder associated with with insufficient stimulator of interferon genes (STING) activity
#1664Selective recovery
#1665Rapamycin 40-O-cyclic hydrocarbon esters, compositions and methods
#1666Immunotherapy against several tumors including gastrointestinal and gastric cancer
#1667PROTEIN POLYMER FUSIONS FOR SUBCUTANEOUS DELIVERY OF SMALL MOLECULES
#1668METHOD FOR INCREASING NEPRILYSIN EXPRESSION AND ACTIVITY
#1669METHODS OF USING ZSCAN4 FOR REJUVENATING HUMAN CELLS
#1670Methods of using ZSCAN4 for rejuvenating human cells
#1671TREATMENT OF EYE DISEASE
#1672MACROPHAGES REDIRECT PHAGOCYTOSIS BY NON-PROFESSIONAL PHAGOCYTES AND INFLUENCE INFLAMMATION
#1673Methods and compositions for treating melanoma
#1674Method for treatment of encephalopathy
#1675SH2 DOMAIN VARIANTS
#1676Recombinant lubricin
#1677Intrathecal delivery of recombinant adeno-associated virus 9
#1678Methods and compositions for modulating lymphatic vessels in the central nervous system
#1679CD47 blockade therapy by HDAC inhibitors
#1680OPTOGENETIC VISUAL RESTORATION USING CHRIMSON
#1681Immunoglobulins and uses thereof
#1682Combined use of GDF traps and erythropoietin receptor activators to increase red blood cell levels
#1683Intrathecal delivery of recombinant adeno-associated virus 9
#1684HYPOXIA-INDUCED MITOGENIC FACTOR
#1685Modulation of TJP1 expression to regulate regeneration of heart cells
#1686POLYPEPTIDES FOR IMPROVED RESPONSE TO ANTI-CANCER THERAPY
#1687Pharmaceutical composition comprising nanoperforator for preventing or treating viral infectious diseases
#1688SPECIFIC OLIGOPEPTIDES AS ANTI-ANGIOGENIC DRUGS
#1689Compositions and Methods for Inhibiting Tumor Cells by Inhibiting the Transcription Factor ATF5
#1690Compositions and methods for treating central nervous system injury
#1691Nutritional formula
#1692Use of FKBP-L polypeptides and nucleic acids for the treatment of obesity
#1693Compositions for the administration of APOA1 and dosages
#1694COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDER
#1695Method for the production of protein complexes and vaccine compositions comprising the same
#1696METHODS OF ADMINISTERING HEPCIDIN
#1697Tear lipocalin muteins binding IL-4 r alpha
#1698POLYPEPTIDES AND USES THEREOF AS A DRUG FOR TREATMENT OF MULTIPLE SCLEROSIS, RHEUMATOID ARTHRITIS AND OTHER AUTOIMMUNE DISORDERS
#1699GENE TRANSFER INTO AIRWAY EPITHELIAL STEM CELL BY USING LENTIVIRAL VECTOR PSEUDOTYPED WITH RNA VIRUS OR DNA VIRUS SPIKE PROTEIN
#1700Treatment for glaucoma and other eye diseases
#1701ANTAGONISTS OF ACTIVIN-ACTRIIA AND USES FOR INCREASING RED BLOOD CELL LEVELS
#1702METHOD OF TREATING AND PREVENTING OCULAR ANGIOGENESIS
#1703BIO-MIMETIC FORMULATION
#1704Methods and Kits for Reducing the Susceptibility of Lipoprotein Particles to Atherogenic Aggregation Induced by Arterial-Wall Enzymes
#1705Adeno-associated virus virions with variant capsid
#1706Norrin regulation of cellular production of junction proteins and use to treat retinal vasculature edema
#1707Methods for enhancing immune responsiveness in an individual toward a target cancer cell population comprising apoptotic cells
#1708Immunotherapy against several tumors, such as lung cancer, including NSCLC
#1709Hemostatic material, preparation method thereof and pharmaceutical composition containing the same
#1710ACTH PROPHYLACTIC TREATMENT OF RENAL DISORDERS
#1711Medical Use of Creg Protein for Prevention or Treatment of Overweight, Obesity and Related Diseases Thereof
#1712COMPOSITIONS AND METHODS OF MODULATING IMMUNE RESPONSE
#1713Compositions, methods and uses comprising teneurin C-terminal associated peptide -1 (TCAP-1) for enhancing muscle performance
#1714Extracellular histones as biomarkers for prognosis and molecular targets for therapy
#1715ApoO FOR USE IN A METHOD FOR TREATING CANCER AND VARIOUS PATHOPHYSIOLOGICAL SITUATIONS
#1716Increasing ATOH1 life to drive sensorineural hair cell differentiation
#1717NNIF and nNIF-related peptides and related methods
#1718USE OF LIPOSOMAL WNT COMPOSITIONS TO ENHANCE OSSEOINTEGRATION
#1719PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF MULTIPLE SCLEROSIS
#1720Heat shock proteins and cholesterol homeostasis
#1721UTERINE CANCER TREATMENTS
#1722Immunostimulating peptides
#1723Conjugate of minoxidil and peptide
#1724Pathways to Generate Hair Cells
#1725Use of C1q/TNF-related protein-1 (CTRP1) to treat fatty liver disease
#1726COMPOSITIONS AND METHODS FOR TREATING NON-AGE-ASSOCIATED HEARING IMPAIRMENT IN A HUMAN SUBJECT
#1727ApoM-Fc fusion proteins, complexes thereof with sphingosine 1-phosphate (S1P), and methods for treating vascular and non-vascular diseases
#1728Compositions and methods for reducing tumor cell growth at a site of solid tumor excision
#1729ISCHEMIA/REPERFUSION INJURY
#1730Methods and compositions for treating Huntington's disease
#1731Compositions and methods for inhibiting T cell exhaustion
#1732Immunotherapy against several tumors, such as lung cancer, including NSCLC
#1733Immunotherapy against several tumors, such as lung cancer, including NSCLC
#1734Dry powder inhaler and system for drug delivery
#1735Implants having a drug load of an oxysterol and methods of use
#1736Methods and systems for noninvasive control of brain cells and related vectors and compositions
#1737HYPO-ALLERGENIC CROSS-LINKED PROTEINS FOR USE IN THE PREVENTION OF AN ALLERGY AGAINST MILK-PROTEINS AND FOR USE IN THE INDUCTION OF ORAL TOLERANCE
#1738COMPOSITIONS AND METHODS FOR CARDIAC REPAIR
#1739Modified T lymphocytes comprising a BAFF antibody-inducible caspase and methods of apoptosis
#1740REGULATORY T CELL MEDIATOR PROTEINS AND USES THEREOF
#1741Removal of serine proteases by treatment with finely divided silicon dioxide
#1742Constructs having a SIRP-alpha domain or variant thereof
#1743Methods for cardiomyocyte survival, proliferation or differentiation by NRG-2
#1744REELIN COMPOSITIONS FOR TREATMENT OF NEUROLOGICAL DISORDERS
#1745Immunotherapy against several tumors, such as lung cancer, including NSCLC
#1746Therapeutic combinations to treat red blood cell disorders
#1747PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING STRESS-RELATED DISEASE, INCLUDING DISC1 PROTEIN OR GENE ENCODING THE SAME
#1748FOXM1 modulators and uses thereof
#1749Peptides and compositions for treatment of joint damage
#1750Method for treating Alzheimer's disease and method for downregulating protein aggregation in brain
#1751C1-INH COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF DISORDERS ASSOCIATED WITH C1 ESTERASE INHIBITOR DEFICIENCY
#1752C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiency
#1753Oncolytic expression vector comprising a nucleic acid comprising a nucleotide sequence encoding GADD34
#1754Structure, manufacturing and uses of human-derived cell-permeable peptides conjugated with specific biologically active cargo peptides
#1755Methods and compositions relating to p62/SQSTM1 for the treatment and prevention of inflammation-associated diseases
#1756Intrathecal delivery of recombinant adeno-associated virus 9
#1757Therapeutic antitumor combination of a TLR4 ligand with other treatments
#1758Treatment of inflammatory conditions by delivery of interleukin-1 receptor antagonist fusion protein
#1759Fusion protein between short form rod-derived cone viability factor and a hydrophilic peptide
#1760Lipopeptides for use in treating liver diseases and cardiovascular diseases
#1761HEPARAN SULFATE BIOSYNTHESIS INHIBITORS FOR THE TREATMENT OF DISEASES
#1762Selective recovery
#1763ISL1-Based Gene Therapy to Treat Hearing Loss
#1764Method of treatment of breast or colon cancer by administering muscle stimulated myokines
#1765Peptides of syndecan-1 for inhibiting angiogenesis
#1766Enhanced reconstitution and autoreconstitution of the hematopoietic compartment
#1767Diarrhea-preventing nutritional composition
#1768Hydrogel toxin-absorbing or binding nanoparticles
#1769Immunotherapies employing self-assembling vaccines
#1770Challenge test for diagnosing subtypes of ASD
#1771Method of identifying ASD phenotype 1 patients
#1772INTRATHECAL DELIVERY OF RECOMBINANT ADENO-ASSOCIATED VIRUS 9
#1773Intrathecal delivery of recombinant Adeno-associated virus 9
#1774GPNMB compositions for treatment of skin wounds
#1775Treatment of a subtype of ASD
#1776Whey preparation for improving brain development
#1777Methods and compositions for reducing infectivity of virus particles comprising an ERGIC-53 polypeptide
#1778Co-activation of mTOR and STAT3 pathways to promote neuronal survival and regeneration
#1779METHOD FOR PREVENTING OBESITY-INDUCED FATTY LIVER BY INHIBITING KCTD17
#1780Compositions comprising choline
#1781Lysosomal degradation of lipids and proteins and method of use thereof
#1782ANTI-CANCER USE OF GENETICALLY MODIFIED HUMAN UMBILICAL CORD PERIVASCULAR CELLS (HUCPVC)
#1783Compositions of phosphorylated tau peptides and uses thereof
#1784COMPOSITIONS AND METHODS FOR TREATING CANCER
#1785Regenerating functional neurons for treatment of disease in the nervous system
#1786Adeno-associated virus vector delivery of microrna-29 to treat muscular dystrophy
#1787GJA1 isoforms protect against metabolic stress
#1788Functionalized metal nanoparticle
#1789Compositions and their use for controlling the nervous system in vivo
#1790Norrin regulation of junction proteins and the use thereof to treat epithelial or endothelial membrane leakage induced edema
#1791USES OF CASEIN COMPOSITIONS
#1792GLA domains as therapeutic agents
#1793CD31SHED AGONISTS FOR USE IN THE PREVENTION AND/OR TREATMENT OF REPERFUSION INJURY
#1794INTRATHECAL DELIVERY OF RECOMBINANT ADENO-ASSOCIATED VIRUS 9
#1795METHOD TO PROTECT AND SEAL THE OCULAR SURFACE
#1796Free Functional Annexin Levels in Plasma as a Biomarker of Cardiovascular Risk
#1797Prion protein-dendrimer conjugates for use in treatment of alzheimer disease
#1798Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
#1799COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF NEURODEGENERATIVE DISORDERS
#1800HIGH DENSITY LIPOPROTEIN FUNCTIONALIZED MAGNETIC NANOSTRUCTURES